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An epidermodysplasia verruciformis-associated squamous cell carcinoma was xenografted to a SCID mouse, and the
resultant tumor was transplanted through mice for 10 generations. Histological and virological features, with replication of
about a thousand copies of the papillomavirus DNA, were the same in both the original carcinoma and the transplanted
tumors. q 1996 Academic Press, Inc.
Epidermodysplasia verruciformis (EV)-associated hu- male CB-17-scid/scid mice aged about 7 weeks. These
mice were called transplanted SCID mice of the firstman papillomaviruses (HPVs) are considered to be a
major etiological factor not only for benign lesions, but generation (hereafter abbreviated to TSM-1). One TSM-
1 died after a week, but the other survived until a spheri-also the squamous cell carcinomas that eventually
evolve from some of them. The latter notion is supported cal tumor (about 8 mm in diameter) was detected under
skin of the back about 24 weeks after the grafting. Theby the finding that EV-accompanied carcinomas so far
examined carry any one of EV-associated HPV DNAs (1) tumor was excised and found to be solid and to have no
cystic cavity. The tumor mass was minced into piecesand produce viral RNA (1 –3). In most of these carcino-
mas, viral DNAs are in abundance (102 –103 copies per as described above and further transplanted into the sub-
cutaneous adipose tissue between the scapulas and un-cell) and are not integrated into cellular DNA (1). To com-
bat such carcinomas, studies, for instance, of inhibitors der the renal capsules of three intact SCID mice, referred
to as TSM-2 below. Two TSM-2 survived until sphericalof papillomavirus-specific helicase activity are neces-
sary. However, to date, no population of cells derived tumors of about 10 mm in diameter developed on their
backs 31 weeks after the grafting. At the present moment,from the carcinomas and conserving several characteris-
tics of the original lesions, including the intracellular ar- tumors have been successfully transplanted from mouse
to mouse for 10 generations, corresponding to a periodrangement of viral DNA, has so far been successfully
of 32 months.adapted to experimental animals as a xenograft or to
Conventionally prepared histological specimens of tu-culture in vitro, and thereby maintained. In order to estab-
mors developing in all the above mice (Fig. 1B for a TSM-lish such an adapted carcinoma, we have grafted excised
7 tumor) provided essentially the same findings as thosepieces of an EV-accompanied carcinoma carrying HPV47
of the original carcinoma, C93 (Fig. 1A). Briefly, clustersDNA to SCID mice. Our present attempt must be distin-
of cells showing variety in nuclear size and hematoxylin-guished from the previous experiment where cells of
stainability, with some groups featuring cornification andbenign lesions including precancerous lesions were
nest formation, were surrounded or interspaced with fi-grafted underneath renal capsules of nude mice and
broblastic cells and collagen fibers. However, numberstransplanted once to other mice (4).
of fibroblastic cells and the amounts of collagen fibersA tumor portion was excised aseptically from an EV-
appeared to be reduced in TSM tumors.associated carcinoma termed C93 described previously
DNAs from the tumors of TSM-1 through TSM-3 were(5). It was minced into eight pieces (about 8 mm3 in size)
analyzed by the Southern procedure in parallel with C93and transplanted into the subcutaneous tissue of the
DNA, all showing the same autoradiographic patternsback and bilaterally beneath the renal capsules of two
(Fig. 2, data for tumors of TSM-1 and -2 are not shown).
The intensity of bands of TSM-3 tumor DNA was also1 On leave from the Department of Dermatology, School of Medicine,
roughly the same as that of C93 DNA, suggesting thatNagoya University.
neither the arrangement nor the number of HPV47 DNA2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 52-763-5233. molecules, in such abundance as 103 per cell, was es-
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FIG. 1. Histological appearance of a squamous cell carcinoma in a patient suffering from epidermodysplasia verruciformis and a tumor developing
in a SCID mouse after transplantation. (A) The primary carcinoma (named C93) appearing in the left parieto-occipital region of the skin. (B) A tumor
in the subcutaneous region of a TSM-7. C, cornification; F, fibroblastic cells and collagen fibers; N, nest of cancer cells. Scale bar, 200 mm.
sentially changed by the successive transplantation. The ment that would have produced such fragments. How-
ever, there remains the possibility that the hybridizationintracellular arrangement of the viral DNA deduced from
these Southern data is as described in our previous pa- could not detect such fragments because of limits to its
sensitivity.per (5), namely, at least a considerable amount of the
viral DNA resides as a circular monomer of viral genome The similarity at the level of histology and the viral
DNA arrangement between TSM tumors and C93, haveunit length in these cells, while the remainder resides
as catenanes, concatemers, or both. The concatemers led us to propose that, at least the characteristic constit-
uents of these TSM tumors, e.g., nest-forming cells, arewere considered more likely to be replicated without inte-
gration into cellular DNA than to be integrated because C93-progeny cells. This notion is supported by the lack
of any evidence that, in nonhuman cells, HPV DNAs canno bands for corresponding fragments including integra-
tion sites were detected with restriction enzyme treat- be propagated without integration into cellular DNA. Fur-
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FIG. 3. Electrophoregram of a DNA segment (262 bp) of the human
beta globin gene PCR-amplified from DNA of a SCID mouse tumor and
other controls as templates. DNAs (300 ng each) of TSM-3 (lane 1),
normal human skin (lane 2), C93 (lane 3), and normal skin of a SCID
mouse (lane 4) were subjected to the PCR with a pair of primers for
amplification of a 262-bp DNA segment of human beta globin gene as
described previously (5). After the reaction, aliquots of the reaction
mixtures were electrophoresed in 4% acrylamide gel, and DNA was
stained with ethidium bromide. DNA fragments produced by treating
pUC19 DNA with HaeIII were introduced into lane 5 as size markers.
FIG. 2. Southern blot hybridization of DNAs of C93 and SCID mouse Arabic numbers at the right margin indicate numbers of base-pairs
tumors with HPV47 DNA as a probe. (A) DNA of a TSM-3 tumor (200 comprising individual markers.
ng) in lanes 1 and 2; C93 DNA in lanes 3 and 4 (200 ng) and in lane
5 (80 ng) were treated with no enzyme (lanes 2, 4); and Nsi I, having
no cleavage sites on HPV47 DNA (lanes 1, 3); BamHI, cleaving HPV47
DNA at only one site (lane 5); and subjected to Southern blot hybridiza-
tion with labeled whole HPV47 DNA as a probe. (B) Normal human
skin DNA (200 ng) supplemented with pUCHPV47 DNA (200 pg), which
had been constructed by inserting the BamHI-treated-linearized HPV47
DNA into the BamHI site of pUC19 DNA, in lane 1, DNA of a TSM-3
tumor in lanes 2 (200 ng) and 4 (80 ng), C93 DNA in lane 3 (200 ng),
and normal human skin DNA (80 ng) supplemented with pUCHPV47
DNA (80 pg) in lane 5 were treated with PstI, cleaving the HPV47
genome into four fragments (lanes 1–3); and BamHI (lanes 4, 5); and
subjected to hybridization with the labeled whole HPV47 DNA as a
probe. All the conditions were as described previously (5). In each
panel, horizontal bars with Arabic numerals indicate the locations of
DNA size markers.
thermore, it could be confirmed by an additional experi-
ment (Fig. 3), in which we subjected DNAs of TSM-tumors
to PCR with a set of primers for amplification of a seg-
ment of the human beta globin gene (5) and found that
all the tumor DNAs so far tested (of TSM-1, TSM-2, TSM-
3, and TSM-5) yielded an amplified DNA fragment of the FIG. 4. Northern blot hybridization of RNA of a SCID mouse tumor
with HPV47 DNA segments as probes. Total RNA extracted from aexpected electrophoretic mobility as efficiently as human
TSM-3 tumor (10 mg on each lane) treated with DNase as describednormal skin DNA and C93 DNA as controls, whereas
previously (7, 8) was subjected to Northern blot hybridization (9),DNA of intact SCID mouse skin did not (Fig. 3). Thus viral
with the 32P-labeled HPV47 DNA segments indicated below as
DNA is propagated in the progeny cells as in the original probes; the whole segment in lane 1, the segment including nn 207 –
C93 cells. If these tumor cells continue to grow as xeno- 687 (nn, nucleotide number of HPV47 DNA) named the E6 probe in
lane 2, the segment including nn 668 – 979 named the E7 probe ingrafts without losing their present characteristics, they
lane 3, the segment including nn 926 – 2785 named the E1 probe inshould provide a model system to study the mechanisms
lane 4, the segment including nn 2786 – 5100 named the E2/E4/L2of viral DNA replication and RNA transcription and to
probe in lane 5, and the segment including nn 5101 – 6208 named
examine the efficacy of therapeutic measures. the L2/L1 probe in lane 6. For the reader’s easier identification,
The easy availability of TSM tumors as compared to probes were named after the major viral ORFs which they cover.
More precise information as to the ORFs were described previouslyoriginal carcinomas prompted us to carry out Northern blot
(10). The E6 and the E7 DNA segments were prepared by PCR usinganalysis on RNA extracted from a TSM-3 tumor (Fig. 4).
appropriate primer pairs as described elsewhere (5) and E1, E2/E4/When probed with whole HPV47 DNA, two dense, faster
L2, L2/L1 by cleaving the viral DNA with a restriction enzyme, PstI.
migrating bands (1.4 and 2.3 kb in size) and two thinner, Total RNAs extracted from normal human and intact SCID mouse
slower migrating bands (3.4 and 4.4 kb in size) were recog- skin were also Northern blotted with the above described probes,
and no signals were detected (data not shown).nized. At the same position as that of the 2.3-kb band, a
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dense band was also observed with the E6 probe, the E7 ACKNOWLEDGMENTS
probe, and the E2/E4/L2 probe, but only a weak band or
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characterized major mRNA (2.1 kb) produced in rat fibro-
blastic cells transformed with whole HPV47 DNA (6), and,
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